Toshiaki Nishihata
Direttore/Membro del Consiglio presso RIBOMIC INC.
Profilo
Toshiaki Nishihata is an Independent Outside Director at Ribomic, Inc. and an Outside Director at Trans Chromosomics, Inc. He was previously the President & Chief Executive Officer at Santen, Inc. and the Director, Head-Research & Development Division at Santen Pharmaceutical Co., Ltd.
He also served as a Director at Santen Holdings U.S., Inc. and as a Manager-Pharmaceutical Development Department at Upjohn Pharmaceuticals Ltd.
Posizioni attive di Toshiaki Nishihata
| Società | Posizione | Inizio |
|---|---|---|
| RIBOMIC INC. | Direttore/Membro del Consiglio | 01/06/2016 |
Trans Chromosomics, Inc.
 Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Direttore/Membro del Consiglio | 01/02/2018 |
Precedenti posizioni note di Toshiaki Nishihata
| Società | Posizione | Fine |
|---|---|---|
| Upjohn Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Presidente | - |
Santen Holdings U.S., Inc.
 Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Direttore/Membro del Consiglio | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| RIBOMIC INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
Santen Holdings U.S., Inc.
Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Finance |
| Upjohn Pharmaceuticals Ltd. | |
Trans Chromosomics, Inc.
Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Commercial Services |
- Borsa valori
- Insiders
- Toshiaki Nishihata
